Hepatoblastoma clinical research: Lessons learned and future challenges
Author:
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Reference21 articles.
1. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group;Ortega;J Clinic Oncol,2000
2. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach-results of the first prospective study of the International Society of Pediatric Oncology;Pritchard;J Clin Oncol,2000
3. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology;von Schweinitz;Eur J Cancer,1997
4. Cisplatin versus cisplatin plus doxorubicin for standard risk hepatoblastoma;Perilongo;N Engl J Med,2009
5. The current management of hepatoblastoma: A combination of chemotherapy, conventional resection, and liver transplantation;Tiao;J Pediatr,2005
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluating the clinical efficacy and limitations of indocyanine green fluorescence-guided surgery in childhood hepatoblastoma: A retrospective study;Photodiagnosis and Photodynamic Therapy;2023-12
2. Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience;Cancers;2023-08-01
3. A nomogram model to predict prognosis of patients with hepatoblastoma;Pediatric Blood & Cancer;2022-08-28
4. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids;Nature Communications;2022-08-25
5. Incidence and 5‐year survival of children and adolescents with hepatoblastoma in the United States;Pediatric Blood & Cancer;2022-05-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3